Publication | Closed Access
Early evaluation of liposomal daunorubicin (DaunoXome®, Nexstar) in the treatment of relapsed and refractory lymphoma
34
Citations
16
References
1997
Year
Hematological MalignancyLymphoid NeoplasiaEarly EvaluationMedicinePathologyLiposomal DaunorubicinCancer TreatmentOncologyCancer ResearchRefractory Lymphoma
| Year | Citations | |
|---|---|---|
Page 1
Page 1